Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 629 | 416 | 2 | 16 | 0 |
| Cost of Goods | 262 | 214 | 0 | 1 | N/A |
| Gross Profit | 367 | 202 | 2 | 14 | N/A |
| Operating Expenses | 7,799 | 5,339 | 4,754 | 5,588 | 3,552 |
| Operating Income | -7,170 | -4,923 | -4,752 | -5,573 | -3,552 |
| Interest Expense | 264 | 285 | 371 | 592 | 260 |
| Other Income | -490 | -380 | -628 | -372 | -262 |
| Pre-tax Income | -7,924 | -5,588 | -5,751 | -6,537 | -4,074 |
| Net Income Continuous | -7,924 | -5,588 | -5,751 | -6,537 | -4,074 |
| Net Income | $-7,924 | $-5,588 | $-5,751 | $-6,537 | $-4,074 |
| EPS Basic Total Ops | -10,666.67 | -14,600.00 | -1,166.67 | -1,600.00 | -33.33 |
| EPS Basic Continuous Ops | -10,680.46 | -14,586.35 | -1,159.96 | -1,603.08 | -24.19 |
| EPS Diluted Total Ops | -10,666.67 | -14,600.00 | -1,166.67 | -1,600.00 | -33.33 |
| EPS Diluted Continuous Ops | -10,680.46 | -14,586.35 | -1,159.96 | -1,603.08 | -24.19 |
| EBITDA(a) | $-6,617 | $-4,361 | $-4,242 | $-5,152 | $-3,116 |